Short sellers made bold moves in the past week. Braveheart Bio saw the most dramatic shift, with SI jumping to 691% of free float from 367% seven days ago. That is a 324-point surge. The stock is a pharmaceutical name with a $1.5bn market cap, and bears are loading up hard.
MiniMed Group also drew fresh interest. SI climbed to 77% of free float, up from 42% a week ago. With a short score of 91, shares available to borrow are nearly zero at 1% availability. That combination makes a squeeze increasingly plausible.
Lucid Group added 8 percentage points to reach 58% SI of free float. The EV maker has been a consistent short target. Bears see no near-term catalyst to change course.
Globant is a surprise mover. The IT services firm saw SI rise from 20% to 30% in a week. That is a notable new bet against a stock not usually in bearish crosshairs.
On the cover side, Chewy saw shorts pull back sharply. SI dropped from 75% to 67% in seven days. Bears may be rethinking a position that has sat elevated for months.
1-800-Flowers continues to look squeezable. SI sits at 79% of free float with days-to-cover above 33. Availability is thin at 24%. Any positive catalyst could trigger a painful unwind.
Taiwan's August export orders hit a record $103bn, up 71% year-on-year per ORTEX alt data. That backdrop gives chip-adjacent longs ammunition against a crowded short book in names like Wolfspeed, where SI remains above 81% of float.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
